NCT07210047 2025-10-07Study of HuL001 in Relapsed/Refractory Multiple Myeloma PatientsHuniLife Biotechnology, Inc.Phase 1/2 Enrolling by invitation21 enrolled
NCT07016737 2025-06-12ESO-Nanjing12Jiangsu Cancer Institute & HospitalPhase 3 Enrolling by invitation79 enrolled